SCHEMBL21173242

SCHEMBL21173242

CC(=O)N1CC(C)Cc2cc(N3CCCCC3)ccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S100B P04271 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
TNF P01375 5/20 0.40
NOD2 Q9HC29 5/20 0.40
NOD1 Q9Y239 5/20 0.40
RAB9A P51151 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C19 P33261 1/20 0.40
GFER P55789 1/20 0.40
ALDH1A1 P00352 3/20 0.39
TP53 P04637 1/20 0.39
KDM4E B2RXH2 1/20 0.39
HPGD P15428 1/20 0.39
RECQL P46063 1/20 0.39
LMNA P02545 2/20 0.39
MEN1 O00255 1/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
PKM P14618 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21172680 0.88 ADRB1 (0.40) SMN1; SMN2TNFNOD2NOD1RAB9A
SCHEMBL21172933 0.88 PRKDC (0.46) TNFNOD2NOD1RAB9AALDH1A1
SCHEMBL21172728 0.88 ADRB1 (0.40) SMN1; SMN2TNFNOD2NOD1RAB9A
SCHEMBL21172640 0.88 PRKDC (0.46) TNFNOD2NOD1RAB9AALDH1A1
SCHEMBL24347304 0.83 MAPT (0.47) SMN1; SMN2TNFNOD2NOD1ALDH1A1
SCHEMBL21172495 0.82 ALDH1A1 (0.47) SMN1; SMN2CYP2C19ALDH1A1LMNAMEN1
SCHEMBL21172877 0.81 SMN1; SMN2 (0.41) SMN1; SMN2TNFNOD2NOD1RAB9A
SCHEMBL24348374 0.80 HPGD (0.49) CYP1A2CYP3A4CYP2C19ALDH1A1KDM4E
SCHEMBL24347983 0.79 MAPT (0.40) SMN1; SMN2ALDH1A1HPGDMAPTKMT2A
SCHEMBL24347656 0.77 TNF (0.47) S100BSMN1; SMN2TNFNOD2NOD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3511323-A1 2,3-DISUBSTITUTED 1-ACYL-4-AMINO-1,2,3,4-TETRAHYDROQUINOLINE DERIVATIVES AND THEIR USE AS BROMODOMAIN INHIBITORS GlaxoSmithKline Intellectual Property (No.2) Limited (GB) 2019-07-17 EP disclosed